Advertisement
CON vs HCA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CON is a Hold and HCA is a Hold.
CON in +1.07% Uptrend, rising for three consecutive days on November 10, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CON advanced for three days, in 100 of 135 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Aroon Indicator entered an Uptrend today. In 54 of 87 cases where CON Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
Bearish Trend Analysis
The 10-day RSI Indicator for CON moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In 12 of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 15 of 27 cases where CON's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
CON broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 21 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.285) is normal, around the industry mean (204.532). P/E Ratio (27.239) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.006) settles around the average of (0.154) among similar stocks. P/S Ratio (2.035) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
HCA's RSI Oscillator recovers from overbought zone
The 10-day RSI Oscillator for HCA moved out of overbought territory on November 06, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 49 instances where the indicator moved out of the overbought zone. In 31 of the 49 cases the stock moved lower in the days that followed. This puts the odds of a move down at 63%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
HCA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on HCA as a result. In 65 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for HCA just turned positive on November 04, 2026. Looking at past instances where HCA's MACD turned positive, the stock continued to rise in 35 of 47 cases over the following month. The odds of a continued upward trend are 74%.
The 50-day moving average for HCA moved above the 200-day moving average on November 09, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +6.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCA advanced for three days, in 247 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 206 of 322 cases where HCA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 19 (best 1 - 100 worst), indicating outstanding price growth. HCA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 29 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-16.135) is normal, around the industry mean (204.532). P/E Ratio (16.380) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.323) is also within normal values, averaging (2.498). Dividend Yield (0.006) settles around the average of (0.154) among similar stocks. P/S Ratio (1.264) is also within normal values, averaging (2.688).
HCA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | |
PROFIT vs RISK RATING 1..100 | 29 | |
SMR RATING 1..100 | 45 | |
PRICE GROWTH RATING 1..100 | 19 | |
P/E GROWTH RATING 1..100 | 56 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CON | HCA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 75% | 2 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 56% | 2 days ago 46% |
| Momentum ODDS (%) | N/A | 2 days ago 73% |
| MACD ODDS (%) | N/A | 2 days ago 74% |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 70% |
| TrendMonth ODDS (%) | 2 days ago 68% | 2 days ago 68% |
| Advances ODDS (%) | 2 days ago 74% | 14 days ago 71% |
| Declines ODDS (%) | 9 days ago 63% | 6 days ago 62% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 49% |
| Aroon ODDS (%) | 2 days ago 62% | 2 days ago 64% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CON’s FA Score shows that 2 FA rating(s) are green while HCA’s FA Score has 2 green FA rating(s).
- CON’s FA Score: 2 green, 3 red.
- HCA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CON’s TA Score shows that 2 TA indicator(s) are bullish while HCA’s TA Score has 5 bullish TA indicator(s).
- CON’s TA Score: 2 bullish, 4 bearish.
- HCA’s TA Score: 5 bullish, 4 bearish.
Price Growth
CON (@Hospital/Nursing Management) experienced а +6.28% price change this week, while HCA (@Hospital/Nursing Management) price change was +8.98% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.75%. For the same industry, the average monthly price growth was +0.37%, and the average quarterly price growth was +10.84%.
Reported Earning Dates
HCA is expected to report earnings on Feb 02, 2027.
Industries' Descriptions
@Hospital/Nursing Management (-5.75% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
CON and
Correlation & Price change
A.I.dvisor indicates that over the last year, CON has been loosely correlated with PNTG. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CON jumps, then PNTG could also see price increases.
| Ticker / NAME | Correlation To CON | 1D Price Change % | ||
|---|---|---|---|---|
| CON | 100% | +0.64% | ||
| PNTG - CON | 45% Loosely correlated | +1.32% | ||
| UHS - CON | 40% Loosely correlated | -0.89% | ||
| AVAH - CON | 38% Loosely correlated | -0.08% | ||
| THC - CON | 38% Loosely correlated | +0.44% | ||
| HCSG - CON | 36% Loosely correlated | +2.10% | ||
More | ||||
HCA and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCA has been closely correlated with UHS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if HCA jumps, then UHS could also see price increases.